27 results on '"Hengstler, Jan G."'
Search Results
2. Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease
3. OS-088-YI Selective ablation of Caspase 8 in hepatocytes ameliorates development of metabolic dysfunction-associated steatohepatitis following hepatocyte-specific JNK deletion
4. LBP-017 Liver-kidney crosstalk: the influence of hepatic oxalate release on kidney gluconeogenesis
5. Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells
6. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis
7. PNPLA3 I148M substitution excerbate NAFLD under a long-term high fat diet
8. NLRP3 and IL-1, but not IL-18, are drivers of hepatocellular carcinoma in two independent murine models
9. Cholestatic liver disease is alleviated by colitis-induced inhibition of bile acid synthesis
10. Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases
11. Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells
12. Reprogramming necroptosis limits immune responses and prevents liver cancer development
13. Biliary epithelial cell-specific RAGE controls ductular reaction-mediated fibrosis during cholestasis
14. Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity
15. Integrated spatial-temporal mathematical liver lobule model for simulation of fibrotic wall formation
16. Liver-specific Tsg101 depletion causes apoptosis, cell death and liver failure
17. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis
18. THU-249 - Inhibition of the renal apical sodium-dependent bile acid transporter prevents cholemic nephropathy
19. WED-470 - PNPLA3 I148M substitution excerbate NAFLD under a long-term high fat diet
20. SAT-227 - NLRP3 and IL-1, but not IL-18, are drivers of hepatocellular carcinoma in two independent murine models
21. FRI-334 - Cholestatic liver disease is alleviated by colitis-induced inhibition of bile acid synthesis
22. Present status and perspectives of cell-based therapies for liver diseases
23. Gut microbiota maintains FXR activation and protects from fatal liver damage in a murine model of primary sclerosing cholangitis
24. Corrigendum to “Gene networks and transcription factor motifs defining the differentiation of human stem cells into hepatocyte-like cells” [J Hepatol 2015;63:934–942]
25. How predictive quantitative modelling of tissue organisation can inform liver disease pathogenesis
26. Distinct role of endocytosis for Smad and non-Smad TGF-β signaling regulation in hepatocytes
27. AS113 - Gut microbiota maintains FXR activation and protects from fatal liver damage in a murine model of primary sclerosing cholangitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.